Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, this medicine should be taken once daily in the evening with a meal.
Take one 10/100/1000 mg extended-release tablet once daily.
Take two 5/50/1000 mg extended-release tablets together once daily.
If the dose of metformin hydrochloride needs to be adjusted, adjust it gradually.
To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew.
In special populations, such as patients with renal impairment, dosage adjustment may be needed according to renal function. No dosage adjustment is required in patients with mild renal impairment.
In patients with an estimated glomerular filtration rate (eGFR) of 45~60 mL/min/1.73m2, this medicine may be used by adjusting the dose of metformin hydrochloride. The starting dose is 500 mg or 750 mg once daily.
If the glomerular filtration rate is below 45 mL/min/1.73m2, discontinue administration immediately.
Improvement of glycemic control in patients with type 2 diabetes mellitus
View approved original textHide original text
This medication helps control blood sugar levels in patients with type 2 diabetes when used in conjunction with dapagliflozin, sitagliptin, and metformin. It particularly contributes to effectively improving blood glucose levels in patients who also follow dietary adjustments and exercise therapy. This aids in more stable blood sugar management.
How to take
Adult dose
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, this medicine should be taken once daily in the evening with a meal.
Take one 10/100/1000 mg extended-release tablet once daily.
Take two 5/50/1000 mg extended-release tablets together once daily.
If the dose of metformin hydrochloride needs to be adjusted, adjust it gradually.
To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew.
In special populations, such as patients with renal impairment, dosage adjustment may be needed according to renal function. No dosage adjustment is required in patients with mild renal impairment.
In patients with an estimated glomerular filtration rate (eGFR) of 45~60 mL/min/1.73m2, this medicine may be used by adjusting the dose of metformin hydrochloride. The starting dose is 500 mg or 750 mg once daily.
If the glomerular filtration rate is below 45 mL/min/1.73m2, discontinue administration immediately.
Precautions
This medication is a combination of three components, each of which aids in the treatment of diabetes. The first component helps lower blood sugar, but rare serious side effects such as severe allergic reactions or pancreatitis can occur; thus, careful monitoring for adverse reactions is necessary during the initial dosing. The second component should not be administered to patients with impaired kidney function or certain diseases, and kidney function must be regularly tested during treatment. The third component can lead to serious side effects such as gastrointestinal disturbances, hypoglycemia, and lactic acidosis, hence caution is required, especially in patients with impaired kidney or liver function. This medication should also be used cautiously in patients at risk for decreased blood volume or hypotension, with regular checks on blood pressure or fluid status being critical. It is safer to avoid use during pregnancy, liver dysfunction, or severe infections. While on treatment, genital and urinary infections, hypoglycemia, pancreatitis, worsened kidney function, severe arthralgia, and skin reactions may occur; any unusual symptoms should prompt immediate consultation with a healthcare provider. Moreover, during this treatment, it is advisable to avoid alcohol consumption, and medication should be temporarily halted in case of sudden surgery or severe dehydration. Regular blood tests and kidney function tests must be conducted before and during treatment to ensure safety. Patients taking this medication should maintain a regular meal pattern and be alert to manage any hypoglycemic symptoms promptly. Lastly, severe skin diseases or rare side effects such as perineal necrosis have been reported in some patients, so it is necessary to inform healthcare professionals of any abnormalities in the skin or genital areas.
Not everyone experiences these, and they can vary from person to person.
Storage
This medication must be kept in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help preserve the medication's effectiveness over time.
Appearance and packaging
Appearance
Yellow to dark yellow, bilaterally convex, oval-shaped extended-release film-coated tablets
Package unit
Bottle - 30 tablets/bottle
Same-ingredient medicines
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.